SCHEMBL6256571

SCHEMBL6256571

Cc1c(C(N)=O)c(-c2ccccc2)nn1-c1ccccc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.78
KMT2A Q03164 4/20 0.78
ALDH1A1 P00352 5/20 0.62
SRC P12931 1/20 0.60
BRAF P15056 1/20 0.60
KDR P35968 1/20 0.60
POLB P06746 1/20 0.54
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP3A4 P08684 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 2/20 0.49
RAB9A P51151 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
PDE4D Q08499 1/20 0.49
CYP1A2 P05177 1/20 0.49
HPGD P15428 1/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1553100 0.88 MEN1 (1.00) MEN1KMT2AALDH1A1SRCBRAF
SCHEMBL2559747 0.85 MEN1 (0.78) MEN1KMT2AALDH1A1SRCBRAF
SCHEMBL6267877 0.85 MEN1 (0.78) MEN1KMT2AALDH1A1SRCBRAF
SCHEMBL28524227 0.83 RAB9A (0.64) MEN1KMT2AALDH1A1POLBCYP2C9
SCHEMBL14553211 0.82 MEN1 (0.75) MEN1KMT2AALDH1A1CYP2C9CYP2C19
SCHEMBL8356085 0.80 SRC (0.74) MEN1KMT2AALDH1A1SRCBRAF
SCHEMBL6264973 0.80 PDE4D (0.73) MEN1KMT2AALDH1A1CYP2C9CYP2C19
SCHEMBL14133085 0.79 ALDH1A1 (0.77) MEN1KMT2AALDH1A1POLBCYP2C9
SCHEMBL17784783 0.78 POLB (0.50) MEN1KMT2AALDH1A1SRCBRAF
SCHEMBL14482198 0.78 MEN1 (0.81) MEN1KMT2AALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005061462-A2 DIARYL PYRAZOLE DERIVATIVES AND THEIR USE AS NEUROKININ-3 RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2005-07-07 WO disclosed